Regis Healthcare Limited (ASX: REG) - Share Price
- Current share price for REG : $6.030
Regis Healthcare Limited (REG), an ASX-listed company, is an aged care provider with over 30 years of experience, supporting more than 10,000 older Australians through Residential Aged Care, Home Care, Day Therapy, Respite Services and Retirement Villages. Having a team of over 12,000 professionals, they deliver personalized care.
REG General Information +
| ASX Code | REG |
| Website | http://regis.com.au |
| Industry/Sector | Health Care Facilities |
| Market Cap ($M) | 1,823 |
| REG Share Price | $6.030 |
| Day High | $6.160 |
| Day Low | $5.950 |
| Last Close | $6.030 |
| REG Share Price Movement | - ( No change ) |
Prices as at 16:40, 10 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Regis Healthcare Limited (REG) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 9¢ | 100% | 12 Mar 2026 | 9 Apr 2026 | - | - | - |
| HFResult | 8.13¢ | 70% | 9 Sep 2025 | 24 Sep 2025 | - | - | - |
| Result | 8.09¢ | 60% | 13 Mar 2025 | 10 Apr 2025 | - | - | - |
See all dividends from Regis Healthcare Limited (REG) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Regis Healthcare Limited (REG) price-sensitive announcements
REG - Regis expects underlying EBITDA at top end of guidance
Regis Healthcare Limited announced that its underlying EBITDA for FY26 is expected to reac
Regis Healthcare Limited (REG)
30 Apr 2026 | 9:18 AM
30 Apr 2026 | 9:18 AM
REG - Appointment of Andrew Kinkade as Managing Director and CEO
Regis Healthcare Limited announced the appointment of Andrew Kinkade as the new Managing D
Regis Healthcare Limited (REG)
29 Apr 2026 | 8:39 AM
29 Apr 2026 | 8:39 AM
REG - REG Investor Presentation 1H FY26
Regis Healthcare Limited, a leader in the Australian aged care sector, presented its H1 FY
Regis Healthcare Limited (REG)
23 Feb 2026 | 8:44 AM
23 Feb 2026 | 8:44 AM
REG - REG Results Announcement 1H FY26
Regis Healthcare Limited reported a substantial increase in its financial performance for
Regis Healthcare Limited (REG)
23 Feb 2026 | 8:44 AM
23 Feb 2026 | 8:44 AM
Regis Healthcare Limited (REG) Recent ASX Announcements
REG Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $59.72 | $19.67 | 16.30% | 32.94 | 16.50 | 2.55% | 50.0% |
| 2025F | $51.35 | $16.92 | 44.40% | 38.30 | 14.50 | 2.24% | 50.0% |
| 2024A | $35.55 | $11.71 | 24.30% | 26.96 | 12.92 | 4.09% | 50.0% |
REG Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| Regis Healthcare Limited (REG) | $1,863M | -6.7687 | 0.0813 | 0.2360 | 34.7826 | 32.1671 | 26.0245 | 2.63% | 2.87% | 3.38% |
| Ramsay Health Care Limited (RHC) | $8,688M | 0.2153 | -0.1674 | 0.2395 | 23.9577 | 28.7746 | 23.2145 | 2.13% | 2.34% | 2.75% |
REG Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 31.60 | -108.60 | 2.03 |
| Market | 0.36 | 12.90 | 1.15 | 0.70 |
| Sector | 0.67 | 21.30 | 1.56 | 3.27 |
REG Directors
| Name | Position | Start Date |
|---|---|---|
| Dr Linda Jane Mellors | Chief Executive Officer, Managing Director | 20 Sep 2019 |
| Professor Christine Constance Bennett | Non-Executive Director | 1 Mar 2018 |
| Mr Ian Gregory Roberts | Non-Executive Director | 2 May 2007 |
| Ms Jodie Lee Leonard | Non-Executive Director | 28 Nov 2023 |
| Ms Sally Margaret Freeman | Non-Executive Director | 17 Jan 2022 |
| Ms Carmel Anne Monaghan | Non-Executive Director | 1 Feb 2026 |
| Mr Graham Hodges | Non-Executive Director, Non-Executive Chairman | 25 Aug 2017 |
Regis Healthcare Limited (REG) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 4 May 2026 | MELLORS, Linda | Sell | Indirect Shares | 223,950 | $6.662 | $1,491,977.200 |
| 25 Feb 2026 | MONAGHAN, Carmel | Buy | Direct Shares | 2,200 | $6.893 | $15,164.460 |
| 2 Sep 2025 | FREEMAN, Sally | Buy | Indirect Shares | 4,805 | $7.792 | $37,440.900 |
See all changes in directors' interest & trades for Regis Healthcare Limited (REG) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
REG Management
| Name | Position |
|---|---|
| Rick Rostolis | Chief Financial Officer |
| Malcolm Peter Ross | Company Secretary,General Counsel |
REG Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Regis Healthcare Limited (REG). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 81,910,479 (27.19%) | Galabay Pty Ltd |
| 32,205,238 (10.69%) | Ashburn Pty Ltd |
REG Calendar of Events
| Date | Event |
|---|---|
| 22 February 2027 | Report (Interim) |
| 24 August 2026 | Report (Annual) |
| 24 August 2026 | Report (Prelim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
